Colorectal cancer screening and surveillance strategy for patients with Diamond Blackfan anemia: Preliminary recommendations from the Diamond Blackfan Anemia Registry

Jeffrey M. Lipton, Christine L.S. Molmenti, Maryam Hussain, Pooja Desai, Maria Florento, Eva Atsidaftos, Adrianna Vlachos

Research output: Contribution to journalArticlepeer-review

Abstract

Diamond Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome characterized by red cell failure, congenital anomalies, poor linear growth, and cancer predisposition. Two previous analyses from the Diamond Blackfan Anemia Registry have quantified DBA as a cancer predisposition syndrome of moderate cancer penetrance. Patients with DBA have a 4.8-fold higher relative risk of developing cancer with an overall cumulative incidence of 13.7% by age 45 years. The two most prevalent solid tumors are colorectal cancer (CRC) and osteogenic sarcoma. Current and evolving data support the institution of cancer screening and surveillance strategies for CRC in DBA.

Original languageEnglish (US)
Article numbere28984
JournalPediatric Blood and Cancer
Volume68
Issue number8
DOIs
StatePublished - Aug 2021
Externally publishedYes

Keywords

  • cancer screening
  • cancer surveillance
  • Diamond Blackfan anemia
  • early onset colorectal cancer

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Colorectal cancer screening and surveillance strategy for patients with Diamond Blackfan anemia: Preliminary recommendations from the Diamond Blackfan Anemia Registry'. Together they form a unique fingerprint.

Cite this